Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2008

01.04.2008 | Article

Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis

verfasst von: J. Corredoira, M. P. Alonso, A. Coira, E. Casariego, C. Arias, D. Alonso, J. Pita, A. Rodriguez, M. J. López, J. Varela

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to evaluate the characteristics of infective endocarditis (IE) caused by S. bovis and compare them to those caused by streptococci of the viridans group (SVG). A prospective study was undertaken considering 55 consecutive cases of IE due to S. bovis and 41 to SVG over 18 years. The study was divided into two periods (1988–1996 and 1997–2005). S. bovis caused 24% of the IE in our centre and constituted the main aetiology for this disease, showing an increase of 358% during the second period studied. Biotype I was responsible for 94.5% of cases and there was a high degree of association with colon tumours (53%). Over the period of the study, 107 patients admitted to our hospital had bacteraemia caused by S. bovis and 310 patients had bacteraemia caused by SVG. In the first group, 55 (51%) were endocarditis cases, but only 41 (13%) of the patients with SVG bacteraemia had endocarditis (p < 0.0001). The distinguishing features of endocarditis caused by S. bovis in comparison with those caused by SGV were: a greater increase in cases during the 2nd period studied (from 12 to 43 vs. from 19 to 22, p < 0.01), a higher percentage of males (93% vs. 71%, p < 0.004), patients significantly older (median age 66 vs. 58.5, p < 0.004), less predisposing cardiopathy (42% vs. 76%, p < 0.0009), more bivalvular involvement (42% vs. 22%, p < 0.04), more spondylitis (9% vs. 0%, p < 0.04), a higher association with colonic tumours (53% vs. 5%, p < 0.0001), and a higher percentage of antibiotic resistance: erythromycin 66% vs. 19%, p < 0.0001; clindamycin 67% vs. 11%, p < 0.0001; cotrimoxazole 77% vs. 30.5%, p < 0.0001, respectively. IE due to S. bovis is an emergent disease in our environment, presenting different characteristics to those produced by SVG.
Literatur
1.
Zurück zum Zitat Parker M, Ball L (1976) Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 9:275–302PubMedCrossRef Parker M, Ball L (1976) Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 9:275–302PubMedCrossRef
2.
Zurück zum Zitat Facklam R (1972) Recognition of group D streptococcal species of human origin by biochemical and physiological test. Appl Microbiol 23:1131–1139PubMed Facklam R (1972) Recognition of group D streptococcal species of human origin by biochemical and physiological test. Appl Microbiol 23:1131–1139PubMed
3.
Zurück zum Zitat Cabell C, Abrutyn E (2002) Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am 16:255–272PubMedCrossRef Cabell C, Abrutyn E (2002) Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am 16:255–272PubMedCrossRef
4.
Zurück zum Zitat Fowler V, Miró J, Hoen B, Cabell C, Abrutyn E, Rubinstein E, Corey G, Spelman D, Bradley S, Barsic B, Pappas P, Anstrom K, Wray D, Fortes C, Anguera I, Athan E, Jones P, van der Meer J, Elliott J, Levine D, Bayer A (2005) Staphylococcus aureus endocarditis. A consequence of medical progress. JAMA 293(24):3012–3021PubMedCrossRef Fowler V, Miró J, Hoen B, Cabell C, Abrutyn E, Rubinstein E, Corey G, Spelman D, Bradley S, Barsic B, Pappas P, Anstrom K, Wray D, Fortes C, Anguera I, Athan E, Jones P, van der Meer J, Elliott J, Levine D, Bayer A (2005) Staphylococcus aureus endocarditis. A consequence of medical progress. JAMA 293(24):3012–3021PubMedCrossRef
5.
Zurück zum Zitat Watanakunakorn C, Burkert T (1993) Infective endocarditis at a large community teaching hospital, 1980–1990. A review of 210 episodes. Medicine (Baltimore) 72:90–102 Watanakunakorn C, Burkert T (1993) Infective endocarditis at a large community teaching hospital, 1980–1990. A review of 210 episodes. Medicine (Baltimore) 72:90–102
6.
Zurück zum Zitat Hoegvik H, Olaison L, Andersson R, Lindberg J, Alestig K (1995) Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 74:324–339CrossRef Hoegvik H, Olaison L, Andersson R, Lindberg J, Alestig K (1995) Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 74:324–339CrossRef
7.
Zurück zum Zitat Hoen B, Alla F, Béguinot I, Bouvet A, Briacon S, Casalta J, Dauchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainnardi J, Ruimy R, Vandenesch F (2002) Changing profile of infective endocarditis. Results of a one-year survey in France in 1999. JAMA 288:75–81PubMedCrossRef Hoen B, Alla F, Béguinot I, Bouvet A, Briacon S, Casalta J, Dauchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainnardi J, Ruimy R, Vandenesch F (2002) Changing profile of infective endocarditis. Results of a one-year survey in France in 1999. JAMA 288:75–81PubMedCrossRef
8.
Zurück zum Zitat Tripodi M, Adinolfi L, Ragone E, Durante E, Fortunato R, Iarussi D, Ruggiero G, Utili R (2004) Clinical features of Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis 34:1394–1400CrossRef Tripodi M, Adinolfi L, Ragone E, Durante E, Fortunato R, Iarussi D, Ruggiero G, Utili R (2004) Clinical features of Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis 34:1394–1400CrossRef
9.
Zurück zum Zitat Ruoff K, Miller S, Garner C, Ferraro M, Calderwood S (1989) Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 27:305–308PubMed Ruoff K, Miller S, Garner C, Ferraro M, Calderwood S (1989) Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 27:305–308PubMed
10.
Zurück zum Zitat Facklan R (2002) What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15:613–630CrossRef Facklan R (2002) What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15:613–630CrossRef
11.
Zurück zum Zitat Osawa R, Sasaki E (2004) Novel observations of genotypic and metabolic characteristics of three subspecies of Streptococcus gallolyticus. J Clin Microbiol 42:4912–4913PubMedCrossRef Osawa R, Sasaki E (2004) Novel observations of genotypic and metabolic characteristics of three subspecies of Streptococcus gallolyticus. J Clin Microbiol 42:4912–4913PubMedCrossRef
12.
Zurück zum Zitat Schlegel L, Grimont F, Ageron E, Grimont P, Bouvet A (2003) Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S.gallolyticus subsp. macedonicus subsp. nov. and S.gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol 53:631–645PubMedCrossRef Schlegel L, Grimont F, Ageron E, Grimont P, Bouvet A (2003) Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S.gallolyticus subsp. macedonicus subsp. nov. and S.gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol 53:631–645PubMedCrossRef
13.
Zurück zum Zitat Poyart C, Quesne G, Trieu-Cuot P (2002) Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of ‘Streptococcus infantarius subsp. coli’ as Streptococcus lutetiensis sp. nov. and of Streptococcus bovis biotype II.2 as Streptococcus pasteurianus sp. nov. Int J Syst Evol Microbiol 52:1247–1255PubMedCrossRef Poyart C, Quesne G, Trieu-Cuot P (2002) Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of ‘Streptococcus infantarius subsp. coli’ as Streptococcus lutetiensis sp. nov. and of Streptococcus bovis biotype II.2 as Streptococcus pasteurianus sp. nov. Int J Syst Evol Microbiol 52:1247–1255PubMedCrossRef
14.
Zurück zum Zitat Duval X, Papastamopoulos V, Longuet P, Benoit C, Perromme C, Leport C, Vilde J (2001) Definite Streptococcus bovis endocarditis: characteristics in 20 patients. Clin Microbiol Infect 7:3–10PubMedCrossRef Duval X, Papastamopoulos V, Longuet P, Benoit C, Perromme C, Leport C, Vilde J (2001) Definite Streptococcus bovis endocarditis: characteristics in 20 patients. Clin Microbiol Infect 7:3–10PubMedCrossRef
15.
Zurück zum Zitat Kupferwasser I, Darius H, Muller A, Mohr-Kahaly S, Westermeier T, Oclert H, Erbel R, Meyer J (1998) Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart 80:276–280PubMed Kupferwasser I, Darius H, Muller A, Mohr-Kahaly S, Westermeier T, Oclert H, Erbel R, Meyer J (1998) Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart 80:276–280PubMed
16.
Zurück zum Zitat Pergola V, di Salvo G, Habib G, Avierinos J, Philip E, Vailloud J (2001) Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with caused by other pathogens. Am J Cardiol 88:871–875PubMedCrossRef Pergola V, di Salvo G, Habib G, Avierinos J, Philip E, Vailloud J (2001) Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with caused by other pathogens. Am J Cardiol 88:871–875PubMedCrossRef
17.
Zurück zum Zitat Moellering R, Watson B, Kunz L (1974) Endocarditis due to group D Streptococci. Comparison of disease caused by Streptococcus bovis with that produced by the enterococci. Am J Med 57:239–250PubMedCrossRef Moellering R, Watson B, Kunz L (1974) Endocarditis due to group D Streptococci. Comparison of disease caused by Streptococcus bovis with that produced by the enterococci. Am J Med 57:239–250PubMedCrossRef
18.
Zurück zum Zitat Grimberg M, Mansur A, Pereira D, Bellotti G, Pileggi F (1990) Streptococcus bovis endocarditis and colorectal neoplasia. Arq Bras Cardiol 54:265–269 Grimberg M, Mansur A, Pereira D, Bellotti G, Pileggi F (1990) Streptococcus bovis endocarditis and colorectal neoplasia. Arq Bras Cardiol 54:265–269
19.
Zurück zum Zitat Ballet M, Gevigney G, Gare J, Delahaye F, Etienne J, Delhaye J (1995) Infective endocarditis due to Streptococcus bovis: a report of 53 cases. Eur Heart J 16:1975–1980PubMed Ballet M, Gevigney G, Gare J, Delahaye F, Etienne J, Delhaye J (1995) Infective endocarditis due to Streptococcus bovis: a report of 53 cases. Eur Heart J 16:1975–1980PubMed
20.
Zurück zum Zitat Weinstein M, Towns M, Quartey S, Mirrelt S, Reiner C, Parmigiang G, Mirrett S, Reiner L, Parnigiani G, Reller L (1996) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602 Weinstein M, Towns M, Quartey S, Mirrelt S, Reiner C, Parmigiang G, Mirrett S, Reiner L, Parnigiani G, Reller L (1996) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602
21.
Zurück zum Zitat Corredoira J, Alonso P, García J, Casariego E, Coira A, Rodriguez A, Pita J, Louzao C, Pombo B, López M, Varela J (2005) Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis 24:250–255PubMedCrossRef Corredoira J, Alonso P, García J, Casariego E, Coira A, Rodriguez A, Pita J, Louzao C, Pombo B, López M, Varela J (2005) Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis 24:250–255PubMedCrossRef
22.
Zurück zum Zitat Durack D, Lukes A, Bright D (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96: 200–209PubMedCrossRef Durack D, Lukes A, Bright D (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96: 200–209PubMedCrossRef
23.
Zurück zum Zitat Hoen B, Chirouze C, Cabell C, Selton-Suty C, Duchene F, Olaison L, Miró J, Habib G, Abrutyn E, Eykyn S, Bernard, Mano F, Corey G (2005) Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the international collaboration on endocarditis. Eur J Clin Microbiol Infect Dis 24:12–16PubMedCrossRef Hoen B, Chirouze C, Cabell C, Selton-Suty C, Duchene F, Olaison L, Miró J, Habib G, Abrutyn E, Eykyn S, Bernard, Mano F, Corey G (2005) Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the international collaboration on endocarditis. Eur J Clin Microbiol Infect Dis 24:12–16PubMedCrossRef
24.
Zurück zum Zitat Steckelberg J, Melton J, Ilstrup D, Rouse M, Wilson W (1990) Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 88:582–588PubMedCrossRef Steckelberg J, Melton J, Ilstrup D, Rouse M, Wilson W (1990) Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 88:582–588PubMedCrossRef
25.
Zurück zum Zitat van der Meer J, van Vianen W, Hu E, van Leeuwen W, Valkenburg H, Thompson J, Michel M (1991) Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in the Netherlands. Eur J Clin Microbiol Infect Dis 10:728–734PubMedCrossRef van der Meer J, van Vianen W, Hu E, van Leeuwen W, Valkenburg H, Thompson J, Michel M (1991) Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in the Netherlands. Eur J Clin Microbiol Infect Dis 10:728–734PubMedCrossRef
26.
Zurück zum Zitat Bouza E, Mensalvas A, Muñoz P, Vasallo F, Moreno Ma, Garcia M (2001) Infective endocarditis—a prospective study at the end of the twentieth century. New predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 80:298–307CrossRef Bouza E, Mensalvas A, Muñoz P, Vasallo F, Moreno Ma, Garcia M (2001) Infective endocarditis—a prospective study at the end of the twentieth century. New predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) 80:298–307CrossRef
27.
Zurück zum Zitat Cartón J, Asensi V, Maradona J, Segovia E, Simarro C, Pérez F, Arribas J (1995) Endocarditis infecciosa sobre válvula natural: perfil epidemiológico y análisis de la mortalidad entre los años 1984 y 1993. Med Clin (Barc) 104:493–499 Cartón J, Asensi V, Maradona J, Segovia E, Simarro C, Pérez F, Arribas J (1995) Endocarditis infecciosa sobre válvula natural: perfil epidemiológico y análisis de la mortalidad entre los años 1984 y 1993. Med Clin (Barc) 104:493–499
28.
Zurück zum Zitat Tornos P, Permanyer-Miralda G, Olona M, Gil M, Galve E, Almirante B, Soler-Soler J (1992) Long-term complications of native infective endocarditis in non-addicts. A 15-year study. Ann Intern Med 117:567–572PubMed Tornos P, Permanyer-Miralda G, Olona M, Gil M, Galve E, Almirante B, Soler-Soler J (1992) Long-term complications of native infective endocarditis in non-addicts. A 15-year study. Ann Intern Med 117:567–572PubMed
29.
Zurück zum Zitat Devriese L, Laurier L, De Herdt P, Haesebrouck F (1992) Enterococcal species isolated from faeces of calves, young cattle and dairy cows. J Appl Bacteriol 72:29–31PubMed Devriese L, Laurier L, De Herdt P, Haesebrouck F (1992) Enterococcal species isolated from faeces of calves, young cattle and dairy cows. J Appl Bacteriol 72:29–31PubMed
30.
Zurück zum Zitat Zarkin B, Lillemoe K, Cameron J, Effron P, Magnuson T, Pitt H (1990) The triad of Streptococcus bovis bacteremia, colonic pathology and liver disease. Ann Surg 211:786–792PubMedCrossRef Zarkin B, Lillemoe K, Cameron J, Effron P, Magnuson T, Pitt H (1990) The triad of Streptococcus bovis bacteremia, colonic pathology and liver disease. Ann Surg 211:786–792PubMedCrossRef
31.
Zurück zum Zitat Lee R, Woo P, To A, Lau S, Wong S, Yuen K (2003) Geographical difference of disease association in Streptococcus bovis bacteraemia. J Med Microbiol 52:903–908PubMedCrossRef Lee R, Woo P, To A, Lau S, Wong S, Yuen K (2003) Geographical difference of disease association in Streptococcus bovis bacteraemia. J Med Microbiol 52:903–908PubMedCrossRef
32.
Zurück zum Zitat Beeching N, Chrismas T, Ellis-Pegler R, Nicholson G (1985) Streptococcus bovis bacteremia requires rigorous exclusion of colonic neoplasia and endocarditis. Q J Med 56:439–450PubMed Beeching N, Chrismas T, Ellis-Pegler R, Nicholson G (1985) Streptococcus bovis bacteremia requires rigorous exclusion of colonic neoplasia and endocarditis. Q J Med 56:439–450PubMed
33.
Zurück zum Zitat Herrero I, Rouse M, Piper K, Alyaseen S, Steckelberg J, Patel R (2002) Reevaluation of Streptococcus bovis endocarditis cases from 1975- to 1985 by 16S ribosomal DNA sequence analysis. J Clin Microbiol 40:1848–1850CrossRef Herrero I, Rouse M, Piper K, Alyaseen S, Steckelberg J, Patel R (2002) Reevaluation of Streptococcus bovis endocarditis cases from 1975- to 1985 by 16S ribosomal DNA sequence analysis. J Clin Microbiol 40:1848–1850CrossRef
34.
Zurück zum Zitat Jean S, Teng L, Hsuch P, Ho S, Luh K (2004) Bacteremic Streptococcus bovis infections at a university hospital, 1992–2001. J Formos Med Assoc 103:118–123PubMed Jean S, Teng L, Hsuch P, Ho S, Luh K (2004) Bacteremic Streptococcus bovis infections at a university hospital, 1992–2001. J Formos Med Assoc 103:118–123PubMed
35.
Zurück zum Zitat Sigman-Igra Y, Schwartz D (2003) Streptococcus bovis revisited: a clinical review of 81 bacteremic episodes paying special attention to emerging antibiotic resistance. Scand J Infect Dis 35:90–93CrossRef Sigman-Igra Y, Schwartz D (2003) Streptococcus bovis revisited: a clinical review of 81 bacteremic episodes paying special attention to emerging antibiotic resistance. Scand J Infect Dis 35:90–93CrossRef
36.
Zurück zum Zitat Clardrige J, Attori S, Zhang Q, Bartell J (2001) 16 S ribosomal DNA sequence analysis distinguishes biotypes of Streptococcus bovis: Streptococcus bovis biotype II/2 is a separate genospecies and the predominant clinical isolate in adult males. J Clin Microbiol 39:1549–1552CrossRef Clardrige J, Attori S, Zhang Q, Bartell J (2001) 16 S ribosomal DNA sequence analysis distinguishes biotypes of Streptococcus bovis: Streptococcus bovis biotype II/2 is a separate genospecies and the predominant clinical isolate in adult males. J Clin Microbiol 39:1549–1552CrossRef
37.
Zurück zum Zitat Leport J, Leport C, Vildé J, Cerf M (1987) Endocardites á Streptococcus bovis et pathologie colique: a propos de 42 observations. Gastroentérol Clin Biol 11:25A Leport J, Leport C, Vildé J, Cerf M (1987) Endocardites á Streptococcus bovis et pathologie colique: a propos de 42 observations. Gastroentérol Clin Biol 11:25A
38.
Zurück zum Zitat Hoen B, Briançon S, Delahaye F, Terhe V, Etienne J, Bigard M, Canton P (1994) Tumors of the colon increase the risk of developing Streptococcus bovis endocarditis: case control study. Clin Infect Dis 19:361–362PubMed Hoen B, Briançon S, Delahaye F, Terhe V, Etienne J, Bigard M, Canton P (1994) Tumors of the colon increase the risk of developing Streptococcus bovis endocarditis: case control study. Clin Infect Dis 19:361–362PubMed
39.
Zurück zum Zitat Klein R, Recco R, Catalano M, Edberg S, Casey J, Steigbigel N (1977) Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 297:800–802PubMedCrossRef Klein R, Recco R, Catalano M, Edberg S, Casey J, Steigbigel N (1977) Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 297:800–802PubMedCrossRef
40.
Zurück zum Zitat Robbins N, Klein R (1983) Carcinoma of the colon 2 years after endocarditis due to Streptococcus bovis. Am J Gastroenterol 78:162–163PubMed Robbins N, Klein R (1983) Carcinoma of the colon 2 years after endocarditis due to Streptococcus bovis. Am J Gastroenterol 78:162–163PubMed
41.
Zurück zum Zitat Panwalker A (1988) Unusual infections associated with colorectal cancer. Rev Infect Dis 10:347–364PubMed Panwalker A (1988) Unusual infections associated with colorectal cancer. Rev Infect Dis 10:347–364PubMed
42.
Zurück zum Zitat González-Quintela A, Martinez-Rey C, Castroagudin J, Rajo M, Domínguez M (2001) Prevalence of liver disease in patients with Streptococcus bovis bacteraemia. J Infect 42:116–119CrossRef González-Quintela A, Martinez-Rey C, Castroagudin J, Rajo M, Domínguez M (2001) Prevalence of liver disease in patients with Streptococcus bovis bacteraemia. J Infect 42:116–119CrossRef
43.
Zurück zum Zitat Teng L Hsueh P, Ho S, Luh K (1999) High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob Agents Chemother 45:3362–3365 Teng L Hsueh P, Ho S, Luh K (1999) High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob Agents Chemother 45:3362–3365
44.
Zurück zum Zitat Streit J, Steenbergen J, Thorne G, Alder J, Jones R (2005) Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother 55: 574–578PubMedCrossRef Streit J, Steenbergen J, Thorne G, Alder J, Jones R (2005) Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother 55: 574–578PubMedCrossRef
45.
Zurück zum Zitat Rodriguez-Avial I, Rodriguez-Avial C, Culebras E, Picazo J (2005) In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility in different groups of species. Antimicrob Agents Chemother 49:820–823PubMedCrossRef Rodriguez-Avial I, Rodriguez-Avial C, Culebras E, Picazo J (2005) In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility in different groups of species. Antimicrob Agents Chemother 49:820–823PubMedCrossRef
46.
Zurück zum Zitat Pelletier L, Petersdorf R (1977) Infective endocarditis: a review of 125 cases from the University of Washington hospitals, 1963–1972. Medicine (Baltimore) 56:287–313 Pelletier L, Petersdorf R (1977) Infective endocarditis: a review of 125 cases from the University of Washington hospitals, 1963–1972. Medicine (Baltimore) 56:287–313
47.
Zurück zum Zitat Venezio F, Westenfelder G, Cook F, Ennerman J, Phair J (1982) Infective endocarditis in a community hospital. Arch Intern Med 142:789–792PubMedCrossRef Venezio F, Westenfelder G, Cook F, Ennerman J, Phair J (1982) Infective endocarditis in a community hospital. Arch Intern Med 142:789–792PubMedCrossRef
Metadaten
Titel
Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis
verfasst von
J. Corredoira
M. P. Alonso
A. Coira
E. Casariego
C. Arias
D. Alonso
J. Pita
A. Rodriguez
M. J. López
J. Varela
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0441-y

Weitere Artikel der Ausgabe 4/2008

European Journal of Clinical Microbiology & Infectious Diseases 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.